The show’s over. Cineworld’s (LSE: CINE) share price halved this week after it confirmed that it was closing all of its UK and US cinemas, with the loss of 45,000 jobs, says Dominic Walsh in The Times. It has now fallen by 90% this year. The closures follow the announcement that the new James Bond firm, No Time to Die, has been postponed until Easter. Cineworld claims this shows that studios “are reluctant to release new blockbusters without guarantees of suitable audiences” and without such films audiences will be unwilling to “consider coming back to theatres against the backdrop of Covid-19”.
Studio bosses should stop being so myopic, says Jim Armitage in the Evening Standard. It’s true that cinemas are closed in New York and Los Angeles, where most film moguls have their “swanky pads”. But in the rest of the world, which accounts for 80% of the global box office, as well as in many US states, “cinemas have been open for months”. While some people may be reluctant to venture out, others “would love to go if there was anything worth watching”. Studios’ “ignorant trampling of decent cinema businesses” could also end up hurting them since studies show that cinema takings “massively outperform” streaming revenues.
The real culprit
There’s certainly something ironic about a film called No Time to Die “bringing down the curtain” on one of the country’s top cinema operators, says Ben Marlow in The Daily Telegraph. Still, Cineworld’s CEO, Mooky Greidinger, has hardly helped his company’s chances of survival: the chain’s debt-fuelled expansion has left it “buckling under an $8bn (£6bn) debt mountain”. It wasn’t until June that he finally abandoned the “fantasy” that he could pull off a £1.8bn takeover of Canada’s Cineplex. Overall, Cineworld needs to raise more money quickly, or it could find itself in a jam that “Bond himself would struggle to escape from”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
If Cineworld wants to borrow any more money from lenders, it will have to pay a “high price”, says Kate Burgess in the Financial Times. With the company “almost certain” to breach its loan covenants by the end of the year, it was forced to offer an interest rate of 11% on its latest tranche of debt, issued last month. Credit-ratings agency Moody’s has downgraded the group again.
With lenders wanting “nose-bleed” interest rates and UK state support “impossible”, the only other option is a rights issue, says Nils Pratley in The Guardian. However, with the company now valued at a mere £346m, it would “require the participation of... Greidinger and his trust”, which owns 20% of the shares, to raise enough money. Their capacity and inclination to inject additional funds are “unknown”. While Cineworld could benefit from a “bumper” 2021 amid the “pent-up supply” of potential blockbusters, its “path to survival in recognisable form” now seems “more uncertain than ever”.
-
8 of the best houses for sale with librariesThis week: the best houses for sale with libraries – from a five-storey Georgian townhouse in Bloomsbury, London, to a 15th-century property with a library in a medieval tower in Lozère, France
-
Investors pull money from UK equities as government warns of “painful” BudgetThe government’s post-election honeymoon period has been short-lived, and investors are shying away from UK equities as a result
-
Qualcomm could acquire rival Intel – but securing the deal won't be easyA tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
-
Modi’s reforms set Indian stocks on fireIndian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
-
How to invest in the quiet market monthsHere's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
-
Spire Healthcare: invest in the booming demand for private healthcareSpire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
-
Are insurance companies a good investment?Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
-
Google's legal challenges – could it be broken up?Google is fending off legal challenges from both the EU and the US. But would breaking it up actually work?
-
Fast-growing bargain stocks the market has missedA professional investor recommends attractive stocks to invest in. This week: Dan Higgins, portfolio manager, Majedie Investments, highlights three favourites
-
Are matchboxes worth collecting?TikTok is reigniting a spark for matchbox collecting. Is there any value in phillumeny or will it fizzle out?
